Skip to content
ppharmaranks
Menu
Class IIOngoing

Nitrofurantoin Capsules recall

FDA recall D-0168-2025 · initiated Dec 4, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jan 8, 2025How we research

AvKARE recalled Nitrofurantoin Capsules in Dec 2024 — an FDA Class II recall (D-0168-2025) because Failed Dissolution Specifications.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 47101; Exp. 02/2026

Quantity recalled: 1016 50-count cartons

Details

Product
Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.
Recalling company
AvKARE
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide USA
Initiated
Dec 4, 2024
FDA report date
Jan 8, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Nitrofurantoin Capsules recalled?
AvKARE recalled Nitrofurantoin Capsules in Dec 2024 — an FDA Class II recall (D-0168-2025) because Failed Dissolution Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Nitrofurantoin Capsules recalled?
Per the FDA enforcement record, the reason for recall D-0168-2025 was: Failed Dissolution Specifications
Is a recalled Nitrofurantoin Capsules dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Nitrofurantoin Capsules are affected?
Distributed: Nationwide USA. The recall covers these lots — Lot # 47101; Exp. 02/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0168-2025.

Source: openFDA Drug Enforcement record D-0168-2025

← All drug recalls